ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer
Authors:
- J. OliveiraJOJ. Oliveira
- V. V. KatajaVKV. V. Kataja
- 1 May 2005
- journal article
- guideline
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_1) , i18-i19
Abstract
1Invited author, Digestive Oncology Unit, University Hospital Gasthuisberg, 3000 Leuven, Belgium; 2Assigned task force member, Instituto Português de Oncologia Francisco Gentil, R. Prof. Lima Basto, 1099–023 Lisboa, Portugal; 3Assigned task force member, University Hospital of Kuopio, Department of Oncology, 70 211 Kuopio, FinlandKeywords
This publication has 9 references indexed in Scilit:
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trialsBritish Journal of Cancer, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerThe Lancet, 1998
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998